---
title: "Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=490922"
source_layer: us_cdc_mmwr
category: surveillance_summary
date: 2022-01-20
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

This report describes the ACIP recommendations for two doses of RZV to prevent herpes zoster and related complications in immunocompromised adults. 

## 詳細內容

This report describes the ACIP recommendations for two doses of RZV to prevent herpes zoster and related complications in immunocompromised adults. 

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:12:57Z*
*資料來源: CDC MMWR*
